PMA supplement
P160046 S004: Ventana PD-L1 (SP263)
FDA PMA supplement · Normal 180 Day Track No User Fee · Ventana Medical Systems, Inc.
Key facts
| Original PMA | P160046 |
|---|---|
| Supplement number | S004 |
| Supplement type | Normal 180 Day Track No User Fee |
| Reason for the supplement | Postapproval Study Protocol |
| Trade name | Ventana PD-L1 (SP263) |
| Generic name | Immunohistochemistry assay, antibody, programmed death-ligand 1 |
| Applicant | Ventana Medical Systems, Inc. |
| Product code | PLS |
| Received date | Apr 3, 2018 |
| Decision date | Jun 1, 2018 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: